CSL Behring Competitors and Similar CompaniesClear all
CSL Behring's competitors and similar companies include Abeona Therapeutics and Octapharma.
 Abeona Therapeutics Abeona Therapeutics is focusing on developing innovative therapies, including gene therapies, for rare diseases, including Sanfilippo Syndrome. |  Octapharma Octapharma is one of the largest human protein manufacturers, developing and producing human proteins from human plasma and human cell lines. | ||
Founding Date | Founding Date 1904 | Founding Date 2013 | Founding Date 1983 |
Type | Type Subsidiary | Type Public | Type Private |
Tags | |||
Locations | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Dallas, US HQ Madrid, ES Cleveland, US New York, US | |
Employees | Employees 7,5692% decrease | Employees 5737% decrease | Employees 12,000 |
Financial | |||
Revenue (est.) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $5.8m (FY, 2025) | Revenue (est.) €2.5b (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods $1.5m (FY, 2025) | Cost of goods €1.7b (FY, 2021) |
Gross profit | Gross profit $4.5b (FY, 2020) | Gross profit $4.3m (FY, 2025) | Gross profit €808.2m (FY, 2021) |
Net income | Net income N/A | Net income $71.2m (FY, 2025) | Net income €438.3m (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Abeona Therapeutics
HQ
Dallas, US
Employees
57↓ 37% decrease
Abeona Therapeutics is focusing on developing innovative therapies, including gene therapies, for rare diseases, including Sanfilippo Syndrome.
View companyOctapharma
HQ
Lachen, CH
Employees
12,000
Octapharma is one of the largest human protein manufacturers, developing and producing human proteins from human plasma and human cell lines.
View company